FDA Inspection 1335088 — Gehring-Montgomery, Inc.

Gehring-Montgomery, Inc. — FEI 3000214933

The FDA completed an inspection of Gehring-Montgomery, Inc. on Aug 26, 2026 in Warminster, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 26, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Warminster, PA (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.